Skip to main content
Clinical Trials/EUCTR2013-004535-72-IE
EUCTR2013-004535-72-IE
Active, not recruiting
Phase 1

A prospective, single-centre, cohort study to determine the pharmacokinetic and pharmacodynamic parameters of teicoplanin in adult patients with haematological malignancy. - PK/PD study of teicoplanin in adults with haematological malignancy.

Tallaght Hospital, Dublin 24, Ireland0 sitesNovember 28, 2013

Overview

Phase
Phase 1
Intervention
Not specified
Conditions
Not specified
Sponsor
Tallaght Hospital, Dublin 24, Ireland
Status
Active, not recruiting
Last Updated
9 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
November 28, 2013
End Date
TBD
Last Updated
9 years ago
Study Type
Interventional clinical trial of medicinal product
Sex
All

Investigators

Sponsor
Tallaght Hospital, Dublin 24, Ireland

Eligibility Criteria

Inclusion Criteria

  • Haematological malignancy; 18 years or above; treated with teicoplanin for at least 3 days; suitable intravenous or intra\-arterial access; written informed consent obtained.
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1\.2 Adults (18\-64 years) yes
  • F.1\.2\.1 Number of subjects for this age range 15
  • F.1\.3 Elderly (\>\=65 years) yes
  • F.1\.3\.1 Number of subjects for this age range 15

Exclusion Criteria

  • Consent not obtained; age \<18 years; administered teicoplanin for \<3 days; limited or no IV or intra\-arterial access; receiving renal replacement therapy; admittance to the Intensive Care Unit.

Outcomes

Primary Outcomes

Not specified

Similar Trials